Discover how biosimilars in Europe expand access, cut costs, and strengthen healthcare systems for a more sustainable future.
From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...
We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.
The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback